<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27893678</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>02</Month>
            <Day>13</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1536-5964</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>95</Volume>
                    <Issue>47</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Medicine</Title>
                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e5402</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>The value of endoscopic Barrett esophagus (BE) surveillance based on histological diagnosis of low-grade dysplasia (LGD) remains debated given the lack of adequate risk stratification. The aim of this study was to evaluate the predictive value of cyclin A expression and to combine these results with our previously reported immunohistochemical p53, AMACR, and SOX2 data, to identify a panel of biomarkers predicting neoplastic progression in BE.We conducted a case-control study within a prospective cohort of 720 BE patients. BE patients who progressed to high-grade dysplasia (HGD, n = 37) or esophageal adenocarcinoma (EAC, n = 13), defined as neoplastic progression, were classified as cases and patients without neoplastic progression were classified as controls (n = 575). Cyclin A expression was determined by immunohistochemistry in all 625 patients; these results were combined with the histological diagnosis and our previous p53, AMACR, and SOX2 data in loglinear regression models. Differences in discriminatory ability were quantified as changes in area under the ROC curve (AUC) for predicting neoplastic progression.Cyclin A surface positivity significantly increased throughout the metaplasia-dysplasia-carcinoma sequences and was seen in 10% (107/1050) of biopsy series without dysplasia, 33% (109/335) in LGD, and 69% (34/50) in HGD/EAC. Positive cyclin A expression was associated with an increased risk of neoplastic progression (adjusted relative risk (RR) 2.4; 95% CI: 1.7-3.4). Increases in AUC were substantial for P53 (+0.05), smaller for SOX2 (+0.014), minor for cyclin A (+0.003), and none for AMARC (0.00).Cyclin A immunopositivity was associated with an increased progression risk in BE patients. However, compared to p53 and SOX2, the incremental value of cyclin A was limited. The use of biomarkers has the potential to significantly improve risk stratification in BE.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>van Olphen</LastName>
                    <ForeName>Sophie H</ForeName>
                    <Initials>SH</Initials>
                    <AffiliationInfo>
                        <Affiliation>aDepartment of Gastroenterology and Hepatology bDepartment of Pathology cDepartment of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ten Kate</LastName>
                    <ForeName>Fiebo J C</ForeName>
                    <Initials>FJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doukas</LastName>
                    <ForeName>Michail</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kastelein</LastName>
                    <ForeName>Florine</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Steyerberg</LastName>
                    <ForeName>Ewout W</ForeName>
                    <Initials>EW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stoop</LastName>
                    <ForeName>Hans A</ForeName>
                    <Initials>HA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spaander</LastName>
                    <ForeName>Manon C</ForeName>
                    <Initials>MC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Looijenga</LastName>
                    <ForeName>Leendert H J</ForeName>
                    <Initials>LH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bruno</LastName>
                    <ForeName>Marco J</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Biermann</LastName>
                    <ForeName>Katharina</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>ProBar-Study Group</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Medicine (Baltimore)</MedlineTA>
            <NlmUniqueID>2985248R</NlmUniqueID>
            <ISSNLinking>0025-7974</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019925">Cyclin A</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C527782">SOX2 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D055748">SOXB1 Transcription Factors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 5.1.-</RegistryNumber>
                <NameOfSubstance UI="D019998">Racemases and Epimerases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 5.1.99.4</RegistryNumber>
                <NameOfSubstance UI="C108352">alpha-methylacyl-CoA racemase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <SupplMeshList>
            <SupplMeshName Type="Disease" UI="C562730">Adenocarcinoma Of Esophagus</SupplMeshName>
        </SupplMeshList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001471" MajorTopicYN="N">Barrett Esophagus</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019925" MajorTopicYN="N">Cyclin A</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004945" MajorTopicYN="N">Esophagoscopy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009426" MajorTopicYN="N">Netherlands</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019998" MajorTopicYN="N">Racemases and Epimerases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055748" MajorTopicYN="N">SOXB1 Transcription Factors</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>2</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27893678</ArticleId>
            <ArticleId IdType="doi">10.1097/MD.0000000000005402</ArticleId>
            <ArticleId IdType="pii">00005792-201611220-00028</ArticleId>
            <ArticleId IdType="pmc">PMC5134871</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2011 Oct 13;365(15):1375-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21995385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Invest. 2012 Feb;42(2):216-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21726217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2008 Mar;103(3):788-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18341497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2011 Jul;106(7):1231-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21577245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2009 May 28;360(22):2277-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19474425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dig Dis. 2011;29(5):499-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22095018</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):659-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17255290</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2006 Oct;55(10):1390-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16682429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2014 Jan;63(1):7-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24165758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2006 Nov;131(5):1392-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17101315</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2011 Mar;140(3):1084-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21376940</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 1987 Jan;92(1):118-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3781178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2013 Dec;62(12):1676-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23256952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Clin Pract Gastroenterol Hepatol. 2004 Dec;1(2):106-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16265072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2010 Jul;105(7):1523-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20461069</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2015 May;64(5):700-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25034523</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 2007 Jun;50(7):920-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17543082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2012 Oct;143(4):927-35.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22771507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2015 Jan;64(1):49-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24721904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 2013 Nov;63(5):630-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24004067</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2012 Jul;61(7):970-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21997553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2003 Jul;9(7):2560-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12855631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 1993 Jul;105(1):40-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8514061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 1999 Dec;94(12):3403-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10606290</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2000 Dec;95(12):3383-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11151865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2014 Mar 26;311(12):1209-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24668102</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2012 May 31;366(22):2074-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22646630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2011 Jul 6;103(13):1049-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21680910</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 2015 Oct;110(10):1420-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26323187</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biometrics. 1977 Mar;33(1):159-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">843571</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2010 Mar;8(3):235-44; quiz e32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19850156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 2009 May;54(6):699-712</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19438745</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>